Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Registrati

Quotazioni in diretta

MRSN Mersana Therapeutics Inc

2,04

0,06 (3,03%)

23 Nov 2024 - Chiuso

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

(1) Aggregate market value based on the closing price per share on Nasdaq on October 3, 2024. (2) Shares outstanding as of October 3, 2024.

Date of Notice

10/07/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

05/10/2023

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Alejandra Carvajal

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Mersana Therapeutics (NASDAQ:MRSN)
Storico
Da Ott 2024 a Nov 2024

Clicca qui per i Grafici di Mersana Therapeutics

Grafico Azioni Mersana Therapeutics (NASDAQ:MRSN)
Storico
Da Nov 2023 a Nov 2024

Clicca qui per i Grafici di Mersana Therapeutics

Notizie Mersana Therapeutics Inc - MRSN

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Venerdì 15 Novembre 2024 (1 settimana fa) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Giovedì 14 Novembre 2024 (1 settimana fa) • Edgar (US Regulatory)

This Particular Biotech Stock Is Soaring On Two Key Announcements
Mercoledì 13 Novembre 2024 (2 settimane fa) • AllPennyStocks.com

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mercoledì 13 Novembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 8-K - Current report
Mercoledì 13 Novembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results
Mercoledì 13 Novembre 2024 (2 settimane fa) • GlobeNewswire Inc.

Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024
Mercoledì 6 Novembre 2024 (3 settimane fa) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 29 Ottobre 2024 (4 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Martedì 29 Ottobre 2024 (4 settimane fa) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Martedì 15 Ottobre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lunedì 7 Ottobre 2024 (2 mesi fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lunedì 7 Ottobre 2024 (2 mesi fa) • Edgar (US Regulatory)

Più Mersana Therapeutics Inc Articoli Notizie

Intesa Sanpaolo

ST Microelectronics

Banca Monte Dei Paschi D...

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea